🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

KEYNOTE-689 Update at #AACR25 Neoadjuvant + adjuvant #pembrolizumab in resectable LA-HNSCC ✅ EFS HR: 0.73 (95% CI 0.58–0.92) ✅ Median EFS: 51.8 mo vs 30.4 mo ✅ CPS ≥10 subgroup: HR 0.66 (95% CI 0.49–0.88) ✅ 2-yr EFS: 75% vs 62% ✅ Early & sustained KM curve separation ✅

.Michael Cecchini and Jia (Jenny) Liu MD PhD co-chair an exciting symposium #AACR25 on new antibody drug conjugate (ADC) and immuno-oncology focused approaches to treating #cancer. AACR Smilow Cancer Hospital

Mic-drop presentation at AACR by Cercek et al Non-operative management of MSI-H tumors showing outstanding responses to single agent IO across tumor types. 117 patients with MSI-H tumors 92% RFS at 2 years 35% of patients without ANY adverse events Option for curative intent

Come join us in Hong Kong for the inaugural ESMO TAT Asia to discuss the latest oncology innovations! 🌏 🏃🏻‍♀️🏃🏻‍♀️🏃🏻‍♀️Abstracts due this week! #ESMOTATAsia25 Herbert Loong, MBBS, FASCO Ben Tran APODDC Tony Mok ESMO - Eur. Oncology Jia (Jenny) Liu MD PhD Ben Solomon Benjamin Besse

Great to take a break from the oncology/cancer research Disneyland that is #AACR25 AACR to connect and brainstorm with the ESMO - Eur. Oncology #ESMO25 #tumoragnosticcommittee to ⬆️ 🧬💊 Looking forward to exciting projects ahead! Vivek Subbiah, MD Niamh Coleman, MD PhD Juliana Beal, MD

The three-part New Drugs on the Horizon Series at the AACR Annual Meeting 2025 wrapped up this morning. A total of 12 first-time disclosures were presented. #AACR25

My thanks to my fellow #coinvestigators for giving me opportunity to present our data of #D3S_001, a novel #KRASG12C inhibitor in #G12Ci pre-treated #NSCLC at AACR #AACR25. The strong & rapid #targetengagement confers superior #efficacy c.f. 1st generation G12Ci. ✔️ORR 30%; DCR

And congrats Dr John Park, PI from Macquarie University NECTA 🇦🇺coauthorship of this impressive work! 👏

📣Final call for early registration! The #ESMOTATAsia25 early registration fees are ending soon. ⏰Register by 14 May and be part of the future of cancer #drugdevelopment. 🔗 ow.ly/knWC50VNTlr

FULL PROGRAM AVAILABLE! MOGA 2025 ASM: Beyond the Checkpoints – Navigating the Immunotherapy Revolution, 12 - 14 August 2025 in Melbourne. Head to moga.org.au/2025-asm to see all confirmed sessions and speakers!

Jia Liu Highlights Multidisciplinary Advances in Head and Neck Cancer at GP Education Night Jia (Jenny) Liu MD PhD Julie McCrossin AM (She/Her) oncodaily.com/blog/head-and-… #Cancer #CancerPatient #CancerCare #MedX #MedNews #MedEd #HeadandNeckCancer #GPEducationNight #Medicine #Health #Oncology #OncoDaily